SMTL ID : 8huk.2 (1 other biounit)

X-ray structure of human PPAR alpha ligand binding domain-lanifibranor-SRC1 coactivator peptide co-crystals obtained by soaking

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.98 Å

Oligo State

monomer

Ligands

1 x BJB: 4-[1-(1,3-benzothiazol-6-ylsulfonyl)-5-chloro-indol-2-yl]butanoic acid(Non-covalent)

BJB.1: 17 residues within 4Å: Chain A: I.77, F.78, C.81, Q.82, T.84, S.85, T.88, Y.119, I.122, F.123, L.126, M.135, F.156, I.159, M.160, L.265, Y.269 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:Q.82, A:I.159, A:L.265 Hydrogen bonds: A:S.85, A:S.85, A:Y.119, A:Y.269

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kamata, S. et al., Functional and Structural Insights into the Human PPAR alpha / delta / gamma Targeting Preferences of Anti-NASH Investigational Drugs, Lanifibranor, Seladelpar, and Elafibranor. Antioxidants (2023)

Release Date

2023-08-09

Peptides

Peroxisome proliferator-activated receptor alpha: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Peroxisome proliferator-activated receptor alpha

Related Entries With Identical Sequence